< Back to previous page

Organisation

Laboratory for Tumor Immunology and Immunotherapy

Division

Main organisation:Department of Oncology
Lifecycle:1 Jul 2016 →  Today
Organisation profile:

In June 2016, the Laboratory of Tumor Immunology and Immunotherapy was founded at KU Leuven. In 2019 Prof An Coosemans, MD PhD, was appointed as the head of the lab. Currently, the lab counts one post-doc, four PhD students, one biostatistician and two lab technicians. The research philosophy of the lab is highly translational. By unraveling the immune biology in patients at diagnosis and during therapy/clinical trials (immune profiling), we can develop more rational based immunotherapy approaches (in mouse models). Immunotherapeutic approaches arise from academic and industry collaborations. Our preclinical findings have already been and will be the basis for well-established clinical trials in the future.  The focus is mainly on ovarian cancer, glioblastoma and uterine sarcoma.  

Follow our research on:

www.facebook.com/LTIILeuven

www.LTII.be

Keywords:Tumor Immunology, Immunotherapy, Ovarian cancer, Glioblastoma, Immune profiling
Disciplines:Oncology, Immunology